Cardiovascular Disease, Clinical & Regulatory
ThromboVision Inc
ThromboVision Inc. has filed a 510(k) application with the Food and Drug Administration for clearance to market the T-Guide.
Nuvelo Inc.
Nuvelo Inc. announced that it has enrolled the first subject in a single-center, Phase 1 trial of recombinant, secreted protein, NU206, the company's lead compound from its Wnt Therapeutics Program.
Nile Therapeutics Inc.
Nile Therapeutics Inc. announced that Mayo Clinic has initiated a Phase Ib, double-blind, placebo-controlled clinical study of CD-NP, a novel chimeric natriuretic peptide, in development for the treatment of acute decompensated heart failure.
Johnson & Johnson
Johnson & Johnson filed for regulatory approval with the U.S.
Astellas Pharma US Inc.
Astellas Pharma US Inc. announced the commercial availability of Lexiscan(TM) injection, an A2A adenosine receptor agonist, for use as a pharmacologic stress agent in radionuclide MPI--a test that detects and characterizes coronary artery disease--i
St. Jude Medical Inc
St. Jude Medical Inc. announced the first patient implants in a clinical study that is investigating whether deep brain stimulation (DBS) therapy will help people who suffer from major depressive disorder, a severe form of depression.
Medtronic Inc.
Medtronic Inc. announced that data from a multi-center, prospective, randomized, single-blinded, controlled investigational study using its neurostimulation system to stimulate the occipital nerves as a po
Dyax Corporation
Dyax Corp. announced that it has treated the final patient in its second Phase 3, 96-patient trial of DX-88, known as EDEMA4, for the treatment of acute attacks of hereditary angioedema (HAE).
Cryocath Technologies Inc
Cryocath Technologies Inc. announced the introduction of Arctic Front(R) in Italy, Belgium and Spain.
ATS Medical Inc.
ATS Medical Inc. announced that Health Canada has approved use of the ATS Open Pivot(R) AP360(TM) Mechanical Heart Valve. The ATS AP360 heart valve maximizes hemodynamic performance with a new supra-annular cuff design that facilitates implantation.
